face_with_colon_three circa 2016.
Tough ‘water bears’ defy intense radiation by apparently wrapping their genetic material in a bizarre protein that can also protect human cells.
Category: biotech/medical – Page 1636
It’s been a long time since there’s been anything like “regular order” in the congressional appropriations process: individual bills passed by the House and Senate, their differences resolved in conference to produce a final version that’s signed into law before the beginning of the fiscal year October 1. Instead, there are usually stopgap funding bills, called continuing resolutions, that extend for weeks or months before a massive omnibus bill, combining up to a dozen different bills, is eventually passed.
Fiscal year 2021 is not going to be the year regular order returns to the appropriations process. The pandemic took hold in the early phases of the appropriations process, just as Congress was starting its usual series of hearings on various parts of the administration’s budget proposal released in early February. Congress instead devoted its attention to series of relief packages during the limited time it was in session this spring.
With no hearings about NASA’s budget proposal by either House or Senate appropriators, the first sign of their views about the agency’s budget had to wait until a few weeks ago. On July 7, the House Appropriations Committee released its draft of the commerce, justice, and science (CJS) spending bill that includes NASA. That bill provides $22.6 billion for NASA, the same amount the agency received in 2020. The White House, by comparison, asked for $25.2 billion for NASA.
Scientists from the University of Missouri, the University of Illinois and Yale University have demonstrated that a combination of pencils and paper could be used to create on-skin bioelectronic devices that might be used to monitor personal health. They’ve fabricated and evaluated a rich variety of pencil-paper-based bioelectronic devices, ranging from biophysical sensors and sweat biochemical sensors to thermal stimulators, ambient humidity energy harvesters, and transdermal drug-delivery systems.
Two groups of nerve cells may serve as “on-off switches” for male mating and aggression, suggests a new study in rodents. These neurons appear to send signals between two parts of the brain—the back tip, or posterior, of the amygdala and the hypothalamus—that together regulate emotions including fear, anxiety, and aggression.
Led by researchers at NYU Grossman School of Medicine, the study showed that male mice struggled to have sex in experiments that blocked signals from one amygdala cell group that communicates with the hypothalamus (MPN-signaling cells). When the same signals were instead bolstered, the animals were not only able to mate but would repeatedly court unreceptive females, something they would not do normally.
Similarly, when the action of a second cell group in the amygdala that also communicates with the hypothalamus (VMHvl-signaling cells) was blocked, the rodents attacked unfamiliar males half as often. When these same neurons were triggered, the mice became unusually aggressive, even attacking their female mates and familiar males.
In the fight against pathogens, most researchers have focused on the diverse immune system arsenal that protects people against infection. However, the lab of Yale microbiologist Jorge Galan explored an evolutionarily ancient defense system possessed by every individual cell in the body.
In work published July 24th in the journal Science, Galan’s lab describes the role played by the mitochondria, the cell’s energy-producing organelle, in creating an anti-microbial compound capable of combatting Salmonella Typhi, the cause of typhoid fever. Using advanced imaging technology, Galan and colleagues show how the compound itaconate, produced in the mitochondria, can penetrate cellular defenses that protect the pathogen and disrupt its metabolism and ability to grow.
Bioprinting could be used for testing potential treatments for Covid-19, cancer and other diseases.
Bioprinting’s importance for pharmaceutical analysis is paramount now, not only for potential Covid-19 treatments, but also for testing treatments for cancer and other diseases. Dr. Atala says that the organoids allow researchers to analyze a drug’s impact on an organ “without the noise” of an individual’s metabolism.
He cited Rezulin, a popular diabetes drug recalled in 2000 after there was evidence of liver failure. His lab tested an archived version of the drug, and Dr. Atala said that within two weeks, the liver toxicity became apparent. What accounts for the difference? An organoid replicates an organ in its purest form and offers data points that might not occur in clinical trials, he said, adding that the testing is additive to, rather than in lieu of, clinical trials.
A study published today (July 27, 2020) in The Lancet Digital Health by UPMC and University of Pittsburgh researchers demonstrates the highest accuracy to date in recognizing and characterizing prostate cancer using an artificial intelligence (AI) program.
“Humans are good at recognizing anomalies, but they have their own biases or past experience,” said senior author Rajiv Dhir, M.D., M.B.A., chief pathologist and vice chair of pathology at UPMC Shadyside and professor of biomedical informatics at Pitt. “Machines are detached from the whole story. There’s definitely an element of standardizing care.”
To train the AI to recognize prostate cancer, Dhir and his colleagues provided images from more than a million parts of stained tissue slides taken from patient biopsies. Each image was labeled by expert pathologists to teach the AI how to discriminate between healthy and abnormal tissue. The algorithm was then tested on a separate set of 1,600 slides taken from 100 consecutive patients seen at UPMC for suspected prostate cancer.
The self-eating process in embryonic stem cells known as chaperone-mediated autophagy (CMA) and a related metabolite may serve as promising new therapeutic targets to repair or regenerate damaged cells and organs, Penn Medicine researchers show in a new study published online in Science.
Human bodies contain over 200 different types of specialized cells. All of them can be derived from embryonic stem (ES) cells, which relentlessly self-renew while retaining the ability to differentiate into any cell type in adult animals, a state known as pluripotency. Researchers have known that the cells’ metabolism plays a role in this process; however, it wasn’t clear exactly how the cells’ internal wiring works to keep that state and ultimately decide stem cell fate.
The industries that shepherd goods around the world on ships, planes and trucks acknowledge they aren’t ready to handle the challenges of shipping an eventual Covid-19 vaccine from drugmakers to billions of people.
Already stretched thin by the pandemic, freight companies face problems ranging from shrinking capacity on container ships and cargo aircraft to a lack of visibility on when a vaccine will arrive. Shippers have struggled for years to reduce cumbersome paperwork and upgrade old technology that, unless addressed soon, will slow the relay race to transport fragile vials of medicine in unprecedented quantities.
Making a vaccine quickly is hard enough but distributing one worldwide offers a host of other variables, and conflicting forces may work against the effort: The infrastructure powering the global economy is scaling down for a protracted downturn just as pharmaceutical companies need to scale up for the biggest and most consequential product launch in modern history.
Are you fascinated with microbiology? Have you ever thought about how to integrate your passion for research and entrepreneurship? The field of microbiology is expanding and being significantly impacted by advancements in technology. Recently, we interviewed Zack Abbott, Ph.D., who is the co-founder of ZBiotics. Zack explained his journey from studying infectious diseases to starting his own business focused on engineering bacteria for positive results. If you’ve ever wondered how you can be on the cutting edge of life sciences research, while working for yourself, read on about Zack’s experience.
1. Can you tell us a little bit about your background before entering the microbiology field?
I did my undergrad at UC Berkeley, where I double-majored in Molecular and Cell Biology and Classical History. I did not leave college thinking I would be a microbiologist. I wasn’t actually sure what I wanted to do, and so I tried out a few different jobs. Eventually, while gaining experience as a research assistant in an HIV lab at UC Davis, I realized that I would be happy with a career in infectious disease.